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Abstract
Background/Purpose: As many as half of all women do not attend postpartum care and receive
desired family planning care. Left with little to no resources for obtaining contraception, many
go on to have subsequent unplanned pregnancies. The American College of Obstetricians and
Gynecologists has stated that offering long-term, reversible contraception at the time of birth
should be considered for these women, yet adoption of this procedure remains low. This
literature review will evaluate the efficacy and advantages of postplacental intrauterine device
placement and barriers to implementing the procedure.
Theoretical Framework: The Health Belief Model can be used to frame conversations about
family planning and contraception choices. Because the Health Belief Model relies on a person
recognizing a need for improved health status and empowers the person to make decisions
autonomously; utilizing this model stresses the need for patients to have postplacental IUD
placement available for choice.
Methods: A search of multiple databases was performed utilizing a PRISMA tool. Eighteen
articles were identified as being relevant to the practice question and were analyzed for data and
results. CINAHL, PubMed, and Scopus were utilized for article search. Articles that were
published in the last ten years, peer-reviewed, and in English were considered. Qualitative
articles regarding IUD placement perspective on breastfeeding or male partner perspective were
excluded.
Results/Findings: Intrauterine device insertion rates were consistently higher in those groups that
received the device postplacentally versus in the clinic postpartum. Rate of continued use at one
year was as high or higher for those receiving devices placed postplacentally compared to in
clinic postpartum, despite an increase in expulsion rates for devices placed postplacentally.
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Parity and route of delivery were the most correlated factors influencing expulsion. Provider
knowledge deficit and insurance reimbursement were identified as barriers.
Implications for Research and Practice: Nurse-midwives should use this information to lobby for
this practice to be offered within facilities as well as at a state level for more expansive coverage
of postplacental intrauterine insertion.
Keywords: Immediate postpartum intrauterine device placement, postplacental LARC,
postplacental IUD, postplacental Mirena, postplacental Paragard, postpartum IUD, postpartum
IUD after vaginal delivery, IUD short interval pregnancy, barriers to postplacental LARC, and
barriers to postplacental IUD.
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Chapter One: Introduction
In the United States each year, 33% of pregnancies have an interpregnancy interval (IPI)
less than the recommended 18 months between the end of one pregnancy and the beginning of
another pregnancy (American College of Obstetricians and Gynecologists [ACOG], 2019).
Women of color, women in lower socioeconomic groups, and other marginalized groups are at
the highest risk for experiencing a shortened interpregnancy interval (ACOG, 2019). Because
interpregnancy interval is a modifiable risk factor for worsened maternal and neonatal outcomes
such as preeclampsia, prematurity, and low birth weight as well as maternal and neonatal
mortality, care should be taken to allow women the greatest access possible to family planning
resources (ACOG, 2019).
With nearly half of all pregnancies in the United State being unplanned, access to family
planning resources is critical. Unplanned pregnancies and short-interval pregnancies contribute
to adverse maternal and neonatal outcomes and perpetuate the cycle of poverty (ACOG, 2019).
Recognizing this, the United States Department of Health and Human Services (DHHS) added
multiple family planning goals to the Healthy People 2030 national goals and now include access
to family planning, reduction in adolescent pregnancy, and increase in use of contraception,
particularly in populations at risk for unintended pregnancy (United States Department of Health
and Human Services [DHHS], n.d.).
Statement of Purpose
The purpose of this paper is to review and synthesize the literature surrounding
immediate postplacental administration of intrauterine devices, specifically identifying its
efficacy and barriers to implementation.
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Evidence Identifying Need
In order to aid in the decrease of unplanned pregnancies and improve perinatal outcomes,
the American College of Obstetricians and Gynecologists (2020) issued Committee Opinion 670,
an expert opinion on the use of immediate postpartum long-acting reversible contraception
(LARC), including intrauterine devices (IUD) and the Nexplanon implant. This committee
opinion states that “LARC should be offered as an effective option for postpartum
contraception”, particularly with adequate counseling on the risks and benefits; hospital
organizations should also work to improve infrastructure to allow for this offering as well as seek
to receive adequate and appropriate reimbursement, both publicly and privately funded
(American College of Obstetricians and Gynecologists [ACOG], 2020). The committee goes on
to recommend that LARC is unable to be administered immediately postpartum and therefore
should be offered in the comprehensive postpartum time period. This ACOG committee
statement is endorsed by the American College of Nurse-Midwives, the Society of MaternalFetal Medicine, the American Academy of Family Physicians, and the Association of Women’s
Health, Obstetric and Neonatal Nurses (ACOG, 2020).
In 2015, the Cochrane Library published a systematic review investigating the efficacy
and appropriateness of offering immediate postplacental IUD placement. This systematic review
concluded that while evidence may be limited, the potential risks of waiting for postpartum
placement, such as the abrupt self-withdrawal of comprehensive postpartum care being reported
as high as 50%, outweigh the risks of placement postplacentally, the largest of those being
expulsion (Lopez et al., 2015). Even considering the potential for expulsion, insertion of
postplacental IUDs have a positive impact on decreasing unintended pregnancies (Cohen et al.,
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2016). The Cochrane systematic review did identify a lack of large population trials and noted
that this is an area for future research (Lopez et al., 2015).
UpToDate addresses postplacental IUD insertion in its larger intrauterine device topic. In
this expert guide, it is noted that postplacental IUD insertion is an acceptable method of offering
contraception and family planning to postpartum patients (Bartz & Pocius, 2019). Bartz and
Pocius also note that the ability to reach the fundus of the immediately evacuated uterus proves
to be the biggest challenge to insertion. UpToDate concludes that research is overall supportive
of routine use of postplacental IUD placement and includes procedural information to lessen
expulsion (Bartz & Pocius, 2019).
While the need and potential advantages are identified through expert opinion and
clinical decision-making tools, barriers such as provider knowledge and misinformation on the
intervention show a critical need for further critical review and synthesis of the currently
available literature. Published Cochrane reviews previously identified that postplacental IUD
insertion should be considered for women at risk for not attending postpartum care; however, the
one-year continuation of postplacental IUD was not identifiable in these reviews (Lopez et al.,
2015).
Significance to Nurse-Midwifery
Midwifery care is hallmarked by a dedication to both public health and ensuring
equitable access to care (American College of Nurse-Midwives [ACNM], 2020). Knowing that
competent midwifery care is fundamentally rooted in advocating for patients’ right to selfdetermination and access to care as well as a dedication to evidence based care, nurse-midwives
must take the time to familiarize themselves ways they may increase access to desired
contraception in a timeframe that is most accessible to patients seeking contraception
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postpartum. Nurse-midwives are the premier champions of autonomous client decisions and as
such, should be interested in postplacental intrauterine device insertion if it is a viable way to
increase access to desired family planning.
Theoretical Framework
The Health Belief Model (HBM) addresses the concerns of short interpregnancy intervals
and supports finding a solution to avoid the morbidity and mortality associated with such
intervals. The HBM originated as a 1950’s U.S. Public Health disease prevention model to help
the United States population avoid disease (LaMorte, 2019). One hallmark of the HBM is the
reliance on an individual’s desire to avoid illness, or in the case of interpregnancy interval
inadequacy, an individual’s realization that shortened intervals of pregnancy result in
complicated maternal and fetal paths, and an individual seeking to mitigate and avoid that risk.
In all, the HBM charges that an individual must believe that they are at risk, that the risk is
significant, that any action taken to mitigate the risk is beneficial, that the obstacles are not so
substantial that the action is unattainable, there is a cue to action, and that self-efficacy is present.
Looking specifically at short interpregnancy interval through the lens of the HBM, it is
apparent that this model is an excellent theoretical framework for the issue. According to the
World Health Organization (WHO), when the HBM was utilized during counseling sessions with
patients, there were fewer unintended pregnancies even though both the HBM and control group
had the same contraceptive use rate; this showed that both the education on adverse outcomes
with unplanned and short interval pregnancy as well as the encouragement of decision ownership
make the HBM the best framework to approach pregnancy prevention conversations (WHO,
2012).
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While there are critics of the Health Belief Model and its potential incompleteness, it
should be noted that healthcare theories merely provide a framework for meeting an actual
person where they are and discovering intrinsic motivation. Historically, contraception decisions
were made completely by the clinician with little patient autonomy, and as such, the HBM
previously made little sense to frame contraceptive care. However, with the progression of
patient autonomy and ownership of care, the evolution of contraception and prevention of
adverse outcomes can transfer back to the patient through the HBM. Because of this evolution to
a partnership of care from a paternalistic approach, even patients who are the most at-risk to
leave care or become pregnant prior to return can be counseled to make this decision in an
autonomous and health promoting manner (Hall, 2012). Rather than determining that this
framework does not fit into family planning, providers should be challenged to make their
dialogue fit a script that incorporates the HBM, knowing that such a model provides a path to a
patient’s desire to achieve health improvement.
Summary
In the United States, 33% of second order or greater pregnancies have a shortened
interpregnancy interval of less than 18 months between the completion of one pregnancy and the
incept of the next (ACOG, 2019). Paired with a nearly 50% unplanned pregnancy rate in the
United States and abysmal maternal and neonatal morbidity and mortality, it is clear that
intervention is necessary. One of the most autonomous ways an individual is able to directly
influence their own pregnancy interval and health is through family planning. While an
individual may have barriers to access care after leaving the hospital postpartum, postplacental
IUD offering is one way to capture at-risk individuals and offer immediate contraception as an
option for family planning. A critical review of the literature surrounding efficacy of method,
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continuation of use, and barriers to facilitating postplacental IUD placement is a necessary step
to exploring how to improve access to postplacental IUD insertion as an option for women
desiring to avoid pregnancy in the postpartum period and beyond.
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Chapter II: Methods
In order to critically evaluate the literature surrounding intrauterine device placement at
the time of placental delivery, a comprehensive search was performed and was depicted utilizing
a PRISMA flow diagram (see Figure 1). This chapter summarizes the search strategy including
databases and search terms utilized, inclusion and exclusion criteria, and quality of literature. In
order to fully appreciate literature surrounding postplacental intrauterine device placement,
reference lists for each study meeting criteria were also evaluated for additional studies.
Search Strategy
In order to give full consideration of all available data for review and synthesis, both the
advantages and disadvantages of postplacental intrauterine device placement were analyzed via
multiple database searches through Cumulative Index to Nursing and Allied Health Literature
(CINAHL), PubMed, and Scopus. Search terms for each database included immediate
postpartum intrauterine device placement, postplacental LARC, postplacental IUD, postplacental
Mirena, postplacental Paragard, postpartum IUD, postpartum IUD after vaginal delivery, IUD
short interval pregnancy, barriers to postplacental LARC, and barriers to postplacental IUD
placement.
Inclusion and Exclusion Criteria
Inclusion criteria required that articles be original research published in peer-reviewed
journals that pertained to postplacental insertion of intrauterine devices, available in the English
language, available in full text, and published after 2010.
Some articles were individually excluded for specific reasons including studies
measuring irrelevant outcomes such as breastfeeding rate or male partner attitude towards
postplacental insertion of device, study settings in low-income countries due to difficulties
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monitoring continued use, rates of infection, and other complications, and studies that explored
early contraception in general rather than specifically postplacental IUD placement.
Summary of Included Records
In total, 72 records were identified through these search terms with 37 remaining after
removing duplicate records. The titles and abstracts of the remaining 37 articles were screened,
resulting in 20 articles. Following a full-text review, 18 articles met the full criteria for inclusion
in this synthesis (see Figure 1). There were five randomized controlled trials, five mixed methods
studies, four retrospective cohort studies, three prospective cohort studies, and one quasiexperimental trial. In general, studies were not limited to comparing copper versus Mirena LNGIUS use; however, one study specifically evaluated the difference in expulsion between these
two types of devices. Fifteen of the studies were based in the United States, two studies were
based in India, and one study was based in Turkey.
Criteria Used for Evaluating Literature
The Johns Hopkins Research Evidence Appraisal Tool was applied to each study
individually to grade the evidence level for each record. This tool appraises articles in a three-tier
evidence level category system, with level I being the most stringently designed and level III
being non-experimental (Dang & Dearholt, 2018). Additionally, the tool evaluates the study
quality as high, good, or low regarding the consistency of results. In total, there were five studies
of level I evidence, six studies of level II evidence, and nine studies of level III evidence. This
was expected as randomization of intrauterine device placement is unlikely. Additionally, twelve
of the studies were of high quality, seven were of good quality, and one was of low quality. The
low-quality study was rated as such because of because high attrition prevented research
completion; however, the potential implications remain important to the discussion.
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With the level of evidence for each record determined, a literature matrix was completed
that synthesized the following for each study: source, level of evidence, purpose, study design,
results, strengths and limitations, implications for current practice, and implications for future
research (See Table 1).
Summary
In order to fully appreciate both the limitations and the efficacy of postplacental
intrauterine device insertion, 18 total articles were synthesized and critically examined. Not only
was device insertion compared to other postpartum time periods of insertion, but limitations of
both provider skill and attitude, as well as system-wide limitations were evaluated as part of this
critical literature review. In order to effectively and objectively assess each study, the Johns
Hopkins Research Evidence Appraisal Tool was used to categorize each record. After limiting
research pieces and evaluating the quality of each, individual matrices were completed to
produce a concise and thorough compilation of valuable data from the literature.
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Chapter III: Literature Review and Analysis
Synthesis of the Literature Matrix
The matrix contains 18 unique pieces of literature. Included in the matrix are five
randomized controlled trials, five mixed methods studies, four retrospective cohort studies, three
prospective cohort studies, and one quasi-experimental trial. An appraisal of each study was
performed utilizing the Johns Hopkins Research Evidence Appraisal Tool (Dang & Dearholt,
2018). Key analysis of purpose, sample/setting, level and quality of evidence, design, results, and
strengths and limitations of the study were critically evaluated and recorded on the literature
matrix (see Table 1). Additionally, author recommendations and implications of the literature, as
they relate to implementing postplacental IUD placement were also considered for each piece of
literature.
Synthesis of Major Findings
The 18 peer-reviewed articles appraised support for postplacental intrauterine device
placement as an appropriate contraception choice. Eleven of the articles included in the matrix
critically assessed the continued use of intrauterine devices when placed postplacentally versus
the traditional interval placement of 6 to 8 weeks postpartum or later. Additionally, there were
three articles that assessed the qualitative opinions of clinicians regarding placing intrauterine
devices within ten minutes of placental expulsion. There was one qualitative assessment of
attitudes regarding postplacental IUD insertion from each U.S. state as well as policies that either
facilitate or act as a barrier to the procedure. Finally, the remaining studies evaluated barriers to
receiving intrauterine devices in the postpartum period after discharge from the delivery stay.
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Evidence of Need
Rates of Intention of IUD Use Postpartum vs. Actual IUD Use Postpartum
Two studies in particular specifically evaluated the rates of receiving an intrauterine
device (IUD) in the postpartum period when it was not offered prior to hospital discharge. Glazer
et al. (2010) surveyed 175 women in the postpartum setting and performed a retrospective cohort
study to assess the reality of postpartum contraception. This study concluded that education
regarding contraception has little impact on the final percentage of counseled women receiving
contraception postpartum. Seventy-seven percent of women surveyed reported discussing birth
control prenatally and 87% reported discussing contraception postpartum. At six months
postpartum, 22% of those desiring intrauterine devices for contraception were still awaiting
placement. When asked, 62% of those women wished that postplacental insertion was an
available option. Of the 175 women that participated in the study, 29% reported not using birth
control at all at six months postpartum and 32% reported using a suboptimal contraceptive
method (Glazer et al., 2010).
In a retrospective cohort study, Bergin et al. (2012) sampled 708 women requesting
intrauterine device placement and the effect that a two-visit policy had on rate of successful
insertion. While this study did not focus solely on the postpartum course, the findings are
relevant as only 385 of the women requesting intrauterine device placement were able to have an
IUD inserted (Bergin et al., 2012). These women also waited an average of 43 days before the
subsequent visit for device placement could take place. Of the women requesting intrauterine
devices for postpartum birth control, only 50% were actually able to have one placed while 60%
of gynecologic patients received a device related to the women not attending the actual insertion
appointment. The further away a patient’s address was from the clinic location, the more likely
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she was to miss attendance of her insertion appointment. Additionally, this study found that 96%
of clinicians surveyed require a two-visit policy to insert an intrauterine device (Bergin et al.,
2012).
Pregnancy Rates with Postplacental IUD Placement vs. Overall Repeat Pregnancy Rate in US
Cohen et al. (2016) evaluated the repeat pregnancy rate in a sample of 82 adolescent
postpartum women aged 13 to 22 years old. During this prospective cohort study, women were
given information about postplacental intrauterine device use and encouraged to choose a birth
control method prior to giving birth. Eighty-two women elected to have post placental
intrauterine device placement with 74 receiving the LNG-IUS and eight choosing a CuIUD.
Fourteen percent requested discontinuation within the first year, along with a 25% expulsion
rate; however, only one pregnancy resulted from expulsion. Only 7.6% of postplacental
intrauterine device users were pregnant at one year postpartum compared to an average
subsequent pregnancy rate of 21% for women aged 13 to 22 in the United States. Participants’
two-year pregnancy rate was 8.1% compared to the national average of 46.5% and at three years,
the subsequent pregnancy rate was 17.7% in participants using an intrauterine device from
postplacental insertion compared to the national average of 83.7% in women ranging from 13 to
22 years of age (Cohen et al., 2016).
The studies included in this critical review demonstrated that prenatal education did not
have a large effect on the rate of IUD insertion at the time of birth; however, an overwhelming
number of women would have chosen to have a postplacental IUD given the long wait time they
experienced postpartum for an IUD placement (Glazer et al., 2010). Additionally, current trends
of practice requiring two-visits prior to insertion were found to be prohibitive for women to
receive desired contraception. Clinic commuting distance was also a factor influencing women’s
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ability to return for IUD placement. Finally, the pregnancy rate of women who were given the
opportunity to receive an IUD postplacentally versus the overall repeat pregnancy rate in the
United States demonstrates a lowered repeat pregnancy rate in the postplacental IUD group.
Timing of Insertion
Expulsion
Three studies consistently showed a higher expulsion rate when intrauterine devices were
placed immediately postplacentally versus the traditional interval of 6 to 8 weeks postpartum
(Dahlke et al., 2011; Kumar et al., 2019; Shukla et al., 2012). The nadir of postplacental
intrauterine device insertion was 7.5% in a large retrospective cohort study (N = 673) at a tertiary
care center in India (Kumar et al., 2019). Shukla et al. (2012) performed a prospective cohort
study of 1,317 women in an Indian tertiary care center, making it one of the largest sample sizes
of postplacental intrauterine device insertion studies. In this large sample, the postplacental
intrauterine device expulsion rate was 10.68% (Shukla et al., 2012). The rates of expulsion from
postplacental insertion were as high as 27% in one study (Dahlke et al., 2011).
Continued Use
Even with higher rates of expulsion with insertions in the immediate postplacental period,
continued rate of use was consistently as high or higher in those who received the device
immediately after expulsion of the placenta (Chen et al., 2010; Crocket et al., 2017; Soon et al.,
2018; Whitaker et al., 2014). Whitaker et al. (2014) performed a randomized controlled trial with
participants randomized into immediate postplacental insertion of LNG-IUS (n = 20) versus a
traditional 6-to-8-week postpartum insertion (n = 22). The rate of use was 60% at 12 months in
the postplacental IUD (PPIUD) group and 40% in the interval placement group despite the
expulsion rate being significantly higher (p < .01) in the PPIUD group (20%) compared to 0% in
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the interval group (Whitaker et al., 2014). Similarly, in a study of 96 intrauterine device
insertions (50 PPIUD, 46 at 6 to 8 weeks), Chen et al. (2010) found that expulsion was still
higher in the postplacental cohort compared to the interval group; however, continued use at six
months was the same.
In a small pilot study, Soon et al. (2018) randomized eleven adolescents into two groups,
with six patients receiving a postplacental intrauterine device and five receiving a postpartum
intrauterine device at 6 to 8 weeks postpartum. All six postplacental placements occurred;
however, at 6 weeks postpartum, two of the five interval placements were not achieved due to
fallout from postpartum care (Soon et al., 2018). At six months, four out of the six postplacental
devices remained with one patient falling out of care and having an unknown status and one
experiencing expulsion and not desiring a replacement device; however, zero of the postpartum
devices remained. Two of the postpartum placements had since been removed and those
adolescents were pregnant at the six-month evaluation (Soon et al., 2018).
Crockett et al. (2017) performed a multi-year retrospective study of 776 women and
found that 7% of women receiving postplacental intrauterine devices requested removal by one
year of use versus 14% of those receiving the device at 6- to 8-week postpartum visits. Multiple
studies concluded similarly positive rates of use at three and six months as well as one year
postpartum despite the significantly higher expulsion rates of postplacental intrauterine devices.
Pain During Insertion
Dahlke et al. (2011) determined that intrauterine devices placed within ten minutes of
placental expulsion or within the 2 days postpartum had lower pain ratings than those placed in
the interval placement period of 6 to 8 weeks postpartum. On a five-point visual analog pain
scale, postplacental placement and extended postpartum placement participants rated the pain of
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insertion as significantly lower (1.07 out of 5 and 1.93 out of 5 respectively), compared to
interval placement participants (3.13 out of 5; p < .001), which was a statistically significant
finding (Dahlke et al., 2011).
Factors Influencing Postplacental Intrauterine Device Expulsion
Through literature synthesis, several variables appeared to influence postplacental
intrauterine device effectiveness and expulsion rates: type of intrauterine device, route of birth,
and parity.
Type of Intrauterine Device
In a randomized controlled trial, Laporte et al. (2020) found that Mirena (LNG-IUS) was
less likely to expel when placed postplacentally compared to the Paragard IUD. The study
randomized women into two groups: those receiving a progesterone containing LNG-IUS
postplacentally (n = 70) and those receiving a copper intrauterine device postplacentally (n = 70).
Copper devices resulted in a higher expulsion rate (36.7%) compared to LNG-IUS (20%; p =
.12), though this was a marginal effect (Laporte et al., 2020).
Route of Birth
One study in particular examine birth route as a factor in postplacental IUD expulsion
rates (Colwill et al., 2018). A retrospective cohort study (N = 169) determined that retention of
intrauterine devices placed postplacentally was higher in cesarean birth (100%) than when placed
postplacentally after a vaginal delivery (84%) when assessed at 6 weeks postpartum (p < .01).
This study did find that cesarean insertion more frequently required ultrasound to ensure that the
device was still in place (Colwill et al., 2018). String visualization occurred 93.1% of the time
with inspection after a vaginal delivery versus only 44.2% of the time after a cesarean delivery.
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Sucak et al. (2015) found in a prospective cohort study (N = 160) that the presence of
labor was a stronger predictor of expulsion than route of delivery. Vaginal deliveries experienced
an 11.3% expulsion rate, whereas laboring cesareans experienced an 8.9% expulsion rate
compared to the non-laboring cesarean expulsion rate of 6.5% at 6 months (Sucak et al., 2015).
These studies determined a difference in expulsion rate when comparing birth routes.
Nonlaboring cesarean sections maintained the lowest rate of expulsion while expulsion rates
were higher for postplacental placements following a laboring cesarean or vaginal birth.
Parity
Two studies noted the increased risk of expulsion among multiparous women (Laporte et
al., 2020; Sucak et al., 2015). Laporte et al. (2020) found that women delivering their third baby
or greater were six times more likely to have a postplacental device expulsion. Similarly, a
prospective cohort study in Ankara, Turkey (N = 160) found that multiparity had a twofold
increase in expulsion and was the only independent factor for expulsion (Sucak et al., 2015).
Barriers to Providing Postplacental Intrauterine Device Insertion
Through a critical review of this literature, five studies were identified that evaluated
provider, facility, and state regulations as barriers to offering and executing postplacental
intrauterine device insertion.
Provider Attitude and Knowledge Gaps
Moniz et al. (2017) performed a survey of 4,609 certified midwives and certified nursemidwives with a 17% response rate (n = 794). This survey revealed that only 10% of these
midwives in the United States felt comfortable placing postplacental intrauterine devices. This
study also showed that 64% of respondents wished they had education on postplacental
intrauterine device use. Forty-one percent reported that this was not the standard of practice at
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their facility, 27% felt unskilled in the insertion, 16.4% reported reimbursement concerns
limiting implementation, and 8.4% avoided the practice related to expulsion or perforation
concerns (Moniz et al., 2017).
Holland et al. (2015) performed a survey of 82 intrauterine device utilizing clinicians,
both physician and nurse-midwife, and discovered that 42% of respondents reported placing a
postpartum intrauterine device at least once. A lack of training was indicated as the most
common reason for not placing postplacental intrauterine devices (73%). Sixty percent of
respondents indicated they were uncomfortable with postplacental intrauterine device use, 43%
appropriately identified the level of expulsion risk associated with the practice, and 25%
incorrectly believed there was an increased risk of organ perforation when intrauterine devices
are inserted in the postplacental period. Participants rarely felt that postplacental intrauterine
devices should never be an option for contraception (1.2%) and some believed postplacental
intrauterine device insertion should always be a contraception option (14.5%; Holland et al.,
2015).
Provider Level of Education
Cole et al. (2019) performed a retrospective cohort study to examine 116 patient charts
with postplacental intrauterine device insertion. This study found that postgraduate year-one
obstetric residents did have a higher expulsion rate; however, they also had the lowest cesarean
delivery rate. The researchers were unable to determine if years of education or route of delivery
was the causative variable in expulsion. Reports from this study revealed that there was no
expulsion rate difference by postgraduate year when vaginal deliveries were isolated for
interpretation, meaning it is likely that years of education was not causative for expulsion but
rather, the route of birth (Cole et al., 2019).
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Jatlaoui et al. (2014) evaluated the expulsion rate in 100 participants for immediate
postplacental intrauterine device insertion after vaginal delivery. While an 11% expulsion rate
was present, no expulsion difference was found when separated by postgraduate year of
residency.
These two studies had opposing results initially, but when both birth route and
postgraduate year were considered together, the expulsion rate was the same across all
postgraduate years.
Reimbursement and State Policies
Moniz et al. (2015) conducted telephone interviews with Medicaid agents representing 40
out of the 50 of the United States. Ten states declined participation. This endeavor revealed that
15 states covered postplacental intrauterine device insertion, nine were considering coverage,
and 16 were not considering coverage (Moniz et al., 2015). Qualitative interviewing in the states
that did cover postplacental intrauterine device insertion noted that device cost was far less than
the cost of pregnancy care or long-term care of a child qualifying for Medicaid and improving
maternal and child health was a priority. Those states not considering postplacental intrauterine
device coverage cited lack of advocacy from community providers and immediate budget
constraints as limiting factors (Moniz et al., 2015). Medicaid representatives that were in states
favorable for the practice saw the short-term cost of IUD placement to be a long-term positive
investment, whereas states not in favor of the practice either determined the device cost was too
high or that providers in that particular state were not campaigning for device availability in the
inpatient setting.
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Strengths and Limitations of the Evaluated Literature
One strength of this literature review was the clear consensus drawn regarding expulsion
rates and continuation of use. All studies consistently reported that postplacental intrauterine
device placement resulted in a higher rate of expulsion than interval placement at 6 to 8 weeks;
however, they also consistently showed that there was a similar or greater continued use of
intrauterine devices when they were placed postplacentally (Chen et al., 2010; Crocket et al.,
2017; Soon et al., 2018; Whitaker et al., 2014). The number of participants in each study was
large enough to draw conclusions related to efficacy of postplacental IUD placement.
Poor participant retention did impact some studies’ ability to draw statistically significant
conclusions. This does, however, highlight the ongoing issue of losing contact with women
postpartum, in both research as well as practice, and stresses the importance of providing
contraception services in a timely manner.
One particular shortcoming of all of the studies is that none focused on consistency with
placement technique with some utilizing ring forceps, others ultrasound guidance, and yet others
using the included deploying device.
Summary
Through an in-depth analysis, the 18 studies included in this review all identified
postplacental intrauterine device insertion as an acceptable, if not preferable, contraception
method for women seeking contraception shortly after birth; however, as many as 60% of
women who desired IUD placement were unable to seek subsequent care to have the IUD placed,
leaving them with no or s contraceptive access.
Despite the increased risk for expulsion due to parity, labor, and vaginal birth, the
continuation rate at one year was still comparable or higher for those who had their IUD placed
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postplacentally compared with insertion at 6 to 8 weeks postpartum. Providers self-identified
their own knowledge deficits as a barrier to initiating this practice. Additionally, states with little
or no desire to reimburse for inpatient postplacental device insertion make the practice
exceedingly difficult.
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Chapter IV: Discussion, Implications, and Conclusions
This critical literature review was performed to assess both the advantages of
postplacental intrauterine device insertion as well as barriers to its facilitation. In total, 18
research studies were analyzed to determine trends in research as well as gaps and implications
to practice. These 18 studies were examined using the John Hopkins Research Evidence
Appraisal Tool to determine data quality and evidence level.
Literature Synthesis
This literature review was founded on the research question “Is postplacental intrauterine
device placement safe and effective; and if so, what are the barriers to implementing this
practice?” During the literature synthesis, the consistent theme identified was that postplacental
IUD placement did have a higher expulsion rate than traditional interval IUD placement;
however, compared to those receiving interval placement, the overall use at one year was as high
or higher in those receiving postplacental IUD placement (Chen et al., 2010). Furthermore, there
was no difference in the safety risks associated with postplacental IUD placement compared to
interval placement (Jatlaoui et al., 2014). Additionally, lack of funding as well as provider
knowledge gaps were identified as main barriers to implementing the procedure (Holland et al.,
2015; Moniz et al., 2015, 2017).
Trends and Gaps in Literature
Studies consistently demonstrated that postplacental IUD placement was just as safe as
interval placement. While there were significantly more expulsions in the groups that received
postplacental IUD placement, the overall use was as high or higher when compared to intended
interval placement at 6 to 8 weeks postpartum. The lack of placement was typically attributed to
patients being lost to follow-up to have the device placed. With as many as 40% of women not
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returning for postpartum care following the birth of a child, this is an enormous care gap that
needs to be addressed (The American College of Obstetricians and Gynecologists [ACOG],
2018). While this was often listed as a study limitation, this is simply more evidence that
contraceptive offerings need to be established in the immediate postpartum period. Another trend
that consistently appeared in the literature was small sample sizes overall. Again, this was
frequently listed as a study limitation; however, with only 7.2% of all women aged 15 to 44
utilizing IUD contraception at any point, the population is extrapolated and expected to be small
(Guttmacher Institute, 2020).
Provider Perception
Several studies looked specifically at provider training and its contribution to successful
continued intrauterine device use (Cole et al., 2019; Sucak et al., 2015). There was no consistent
outcome. One study did show that level of postgraduate education was associated with expulsion
outcome but when birth route was isolated, expulsion rates were similar for all postgraduate
levels (Cole et al., 2019). Multiple studies collected qualitative data from both physicians and
advanced practice clinicians and several knowledge gaps regarding technique and identifying
risk factors were identified (Moniz et al., 2017). The overall trend for providers was that they felt
untrained in postplacental IUD placement. Moniz et al. (2017) found that providers consistently
reported that they would likely offer postplacental IUD placement with more training or that they
would like to offer the service; however, the facility did not have the ability to offer this service
due to the inability to capture charges for the placement. Further study is required to determine
provider role in both rate of use as well as barriers to facility implementation of the practice.
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Patient Perspective
Only one study discussed the patient perspective on offering postplacental intrauterine
device placement. Glazer et al. (2011) surveyed women that did receive postplacental IUD as
well as those that were not able to have placement. Those that did receive a postplacental IUD
were pleased with being able to obtain the contraception. Of the women still waiting placement
at six months postpartum, an overwhelming majority (62%) wished they had been able to receive
an IUD prior to leaving the hospital. Additionally, significantly less discomfort was reported
with postplacental insertion versus traditional interval placement (Dahlke et al., 2011).
Additional qualitative research is necessary to determine satisfaction, as most studies focused on
efficacy. While one may assume satisfaction is related to continued use, that should be
demonstrated statistically.
Cost as a Barrier
Few studies focused solely on barriers to instituting postplacental IUD placement. One
study found that state Medicaid reimbursement was often associated with use of postplacental
IUD (Moniz et al., 2015). Only 15 states in the United States currently have Medicaid coverage
for inpatient IUD use. Device reimbursement is a barrier to implementation; however, it is only
one layer of the barriers that exist and more studies, both qualitative and quantitative, must be
conducted to identify all barriers and ways they may be eliminated.
Implications for Midwifery Practice
Even though postplacental IUD placement has been consistently demonstrated to be a
safe and effective way to decrease unplanned pregnancy rates and in turn, increase the length of
time between pregnancies, adoption of the practice is low. The two most common barriers to
implementation are provider knowledge base and reimbursement. In a study performed by the
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American College of Nurse-Midwives, only 10% of respondents felt comfortable placing a
postplacental intrauterine device with 62% desiring training on the topic (Moniz et al., 2017).
Given the Midwifery Hallmarks of both evidence-based care as well as the right to selfdetermination, nurse-midwives are poised to be the perfect lobbyists for postplacental IUD
placements (ACNM, 2020). The evidence is clear that this procedure should be offered,
particularly in populations at risk for loss of follow-up care. Additionally, patients’ right to selfdetermination includes the ability to decide if and when a subsequent pregnancy should occur.
With up to 40% of women never returning for postpartum care, a significant number of women
continue life without the appropriate knowledge or tools to prevent unwanted pregnancy
(ACOG, 2018). Postplacental IUD placement is a critical way for nurse-midwives to advocate
for patients.
Surprisingly, prenatal education had little to do with ultimate choice of contraception.
Glazer et al. (2011) corroborated previous studies that prenatal counseling did little to affect
overall contraception use. Seventy-seven percent of respondents in this study recalled discussing
IUDs in the prenatal period but reported that it had little to do with their decision (Glazer et al.,
2011). While it is helpful to know that contraception education needs to be addressed differently
or more frequently, there is a need for further research to determine the best way to address
family planning in the prenatal and hospital postpartum course.
There is little additional training necessary for postplacental IUD placement. Cole et al.
(2019) demonstrated adequate placement of postplacental IUD placement after a single email
training was offered. Theoretically, offering a one-time in-service or virtual training should be
sufficient to execute the practice in facilities. Equipped with the low-risk training investment and
the evidence that this is a safe and preferred method of contraceptive offering, nurse-midwives
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should feel empowered to offer this information to facilities to help create a more equitable
family planning environment, particularly in populations at risk for loss of follow-up care in the
postpartum period.
Beyond a willingness to receive training and individually adopt the practice of
postplacental intrauterine device placement, Certified Nurse-Midwives (CNMs) are in an
excellent position as patient advocates to campaign for more states to reimburse fairly for this
procedure immediately postpartum. In addition to promoting adoption at the state and facility
levels, CNMs should be looking for ways to spread accurate training regarding both the
procedural technique and the safety and efficacy of the practice. Furthermore, nurse-midwives
are able to increase incidence of use with thorough patient counseling regarding immediate
contraceptive options throughout pregnancy and on arrival for birth.
Integrating the Health Belief Model (HBM)
The Health Belief Model (HBM) relies on an individual’s desire to avoid illness, or in the
case of postpartum family planning, subsequent pregnancy with its cascade of potential negative
health and socioeconomic sequelae. The HBM trusts that individuals are given the knowledge
that they are at risk for an adverse outcome and that certain actions to mitigate risks are seen as
beneficial. One key aspect of the HBM is that actions are attainable and obstacles are not so great
that manipulation is futile. In this case, knowing that 40% of women are unable to attend
postpartum care visits demonstrates a need to remove barriers. Additionally, other barriers for
those seeking care, such as the average 43-day delay between requesting an IUD and placement
of a device, further decrease the number of women able to practice self-determination with
family planning and prevent undesired pregnancy (Bergin et al., 2012). This prohibitive
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environment makes postplacental IUD placement a valid solution to enabling women to mitigate
risk.
Giving women information multiple times prenatally and on admission for birth allows
women to take ownership of their fertility, particularly when paired with education about risks of
shortened interpregnancy interval. Utilizing the Health Belief Model and knowing the risks of
unwanted pregnancy and potential expulsion of a postplacental intrauterine device, it is likely
that many women, feeling ownership and empowerment, would elect to have an IUD placed and
return for potential expulsion.
Conclusion
This critical literature review consistently found that postplacental intrauterine device
placement is a valid option for women seeking immediate contraception post birth or those
women at risk for not attending postpartum care. Several studies concluded that postplacental
IUD placement should even be a preferred contraceptive offering for those populations at risk to
not return for postpartum care after leaving the birthing facility. In total, 18 research studies were
evaluated utilizing the Johns Hopkins Research Evidence Appraisal Tool with pertinent findings
related to device expulsion, safety, continued use at time intervals such as three months, six
months, and one year, provider knowledge gaps, variable state insurance practices, and patient
perceptions. Identified barriers came from state reimbursement issues and provider knowledge
gaps. While factors facilitating implementation of this procedure were not specifically studied,
locations with access to the devices in the inpatient obstetric setting were most likely to be able
to employ the technique.
Nurse-midwives are in a pivotal role with regards to promoting use of postplacental IUD
placement. The unique hallmarks that guide the profession combined with utilizing the Health
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Belief Model are perfectly aligned to encourage this practice be initiated to allow for evidencebased care and patient right to self-determination. Time spent counseling women during the
prenatal and birthing periods allows for adjustments to education to ensure that women are able
to make informed choices either prenatally or at the time of admission for birth. With the
overwhelming evidence of its safety and efficacy, postplacental intrauterine device insertion is
one critical way that nurse-midwives can positively impact the rate of unplanned pregnancy and
shortened interpregnancy interval in the United States.
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Table 1. Literature Review Matrix
Source: Bergin, A., Tristan, S., Terplan, M., Gilliam, M. L., & Whitaker, A. K. (2012). A missed
opportunity for care: Two-visit IUD insertion protocols inhibit placement. Contraception,
86(6), 694–697. https://doi.org/10.1016/j.contraception.2012.05.011
Purpose/Sample
Purpose:
Examine the
potential for two
visit IUD process
to limit access to
birth control
Sample/Setting:
708 women
requesting IUD in
a primarily low
income clinic with
a mostly Medicaid
insured population
in an urban
university medical
center
Level of
evidence:
II
Quality of
evidence:
High

Design
(Method/Instruments)
Retrospective study
Study examined 708 women
who requested IUD over a
one year period. A two visit
IUD policy was initiated,
requiring one visit to request
an IUD and a second one 2-3
weeks later for placement.
Retrospective review of
orders and paper charts was
utilized to determine rate at
which women actually
obtained IUD.

Results

Strengths/Limitations

Of the 708 women
requesting IUD, only
385 were actually able
to return for placement
with a median wait of
43 days between
appointments. 50% of
women requesting IUD
at pregnancy related
visits returned for
placement and 60% of
women requesting at
GYN visits returned.
Single women were
less likely to return
than married women.
Race, age, and type of
IUD did not have an
impact.

Strengths:
-Because women were
IL Medicaid, they
could not attempt
placement at a different
provider as the state
only allows one order.
-Large sample size.

Conclusion:
Two-visit IUD
placement is
prohibitive to desired
contraception.

Limitations:
Utilizing medical
billing records limited
statistics that could be
assessed.
-Unable to determine
reason for
nonplacement based on
retrospective nature.
-Limited population
diversity.
-No comparison to rate
with single visit
placement.

Author Recommendations: Single visit IUD placement significantly increases rate of use.
Implications: Postpartum women only have desired postpartum IUD placed at a 50% rate in the
outpatient setting. 96% of clinicians report a 2 visit policy related to insurance, further limiting options
for women. An average of 43 days passed between being able to request an IUD and have one placed.
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Source: Chen, B. A., Reeves, M. F., Hayes, J. L., Hohmann, H. L., Perriera, L. K., & Creinin, M. D.
(2010). Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal
delivery: a randomized controlled trial. Obstetrics and Gynecology, 116(5), 1079–1087.
doi:10.1097/AOG.0b013e3181f73fac
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Prospective cohort study Conclusion:
Strengths:
Compare use of
At six months, use was
Random assignment
LNG-IUS at 6
similar in both groups.
into group of women all
Pregnant women that
months postpartum
Even though expulsion
desiring LARC
desires LNG-IUS were
when placed
randomly assigned at the was significant higher in prevented inadvertent
postplacentally vs.
the immediate group,
bias coming from the
time of labor to either
delayed insertion.
sample. Scrupulous
immediate postplacental women sought care for
replacement. This paired removal of women not
IUD placement or
Sample/Setting:
with women being less
meeting criteria allowed
traditional 6-8 week
50 postplacental
likely to follow-up
for good internal
postpartum IUD
placement
validity.
placement with expelled postpartum and request
46 delayed until 6-8 IUDs replaced if patients an LNG-IUS accounts for
weeks placement
the similar use in both
Limitations:
requested.
populations.
Limitations included
Disqualifiers were
inconsistent insertion
Johns Hopkins
intrapartum hemorrhage
techniques and skill
Evidence
or infections, as well as
level.
Appraisal
cesarean.
Strength: I
Phone surveys
Quality: Good
performed at 3 and 6
months post-placement.

Author Recommendations:
Offer postplacental LNG-IUS in populations at risk to not seek delayed insertion. US for high fundal
placement to avoid complications of expulsion seen in study.
Implications: Placing IUDs immediately post placentally is similarly effective to that of the traditional
last visit of a postpartum course at six to eight weeks postpartum. Even though the rate of use at six
months is similar, postplacental IUD placement had an expulsion rate of 24% compared to the 6-8
week placements. Because of this postplacental IUD insertion should be considered in populations
where postpartum visit attendance is low. If the likelihood of attending postpartum appointment at 6-8
weeks is high, reserve placement for then.

43
Source: Cohen, R., Sheeder, J., Arango, N., Teal, S. B., & Tocce, K. (2016). Twelve-month
contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery
contraceptive implants or postplacental intrauterine devices. Contraception, 93(2), 178–183.
https://doi.org/10.1016/j.contraception.2015.10.001
Purpose/Sample
Purpose:
To determine one
year continuation
and repeat
pregnancy rate
with postplacental
IUD (PPIUD)

Design
(Method/Instruments)
Prospective Cohort Study

Results

Strengths/Limitations

14% requested
Strengths:
discontinuation within -All patients included
Women were given PPIUD
the first year. 25%
desired the type of
information in the second
experienced expulsion. contraception they
trimester and all women
94% of expulsions
received, therefore
through CAMP were
were within 12 weeks
motivation for success
encouraged to choose a
PP. PP with 15/17
allowed for best case
method of birth control prior
expulsions recognized results.
Sample/Setting:
to birth. Those that chose
by participant.
-Prospective non82 13-22 year old PPIUD were included in this
randomization.
7.6 pregnancy rate at
women receiving
study. Records were
-Excellent follow-up
one year. 1 pregnancy
LNG-IUS (n = 74) reviewed at 6 and 12 months from expulsion and
database for
and CuIUD (n =
postpartum to determine IUD rest were from
completeness of
8) at Children’s
continuation and pregnancy
requested removal and results.
Hospital
rate.
Limitations:
no reliable
Colorado.
- Convenience
contraception.
sampling vs. large scale
Conclusion:
Level of
randomized population
Continued use of IUD
evidence:
- Sample limited to
at one year was high.
II
younger patients
and even though
expulsion was higher
Quality of
than baseline IUD
evidence:
expulsion, overall use
High
at one year is similar.
Also, pregnancy rate
extensively lower than
general pregnancy rate
for women 13-22 years
old.
Author Recommendations: Providers can recommend PPIUD for short interpregnancy interval
pregnancy prevention; however, because of increased expulsion rates, follow-up should be emphasized.
Implications: Only 7.6% of participants were pregnant at one year compared to the average of 21% in
the U.S. Participants had 2 year pregnancy 8.1 and 3 year 17.7 vs non-LARC CAMP participants
having a 2 year pregnancy rate of 46.5% and 83.7% at 3 years.
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Source: Cole, M., Thomas, S., Mercer, B. M., & Arora, K. (2019). Impact of training level on
postplacental levonorgestrel 52 mg intrauterine device expulsion. Contraception, 99(2), 94–97.
https://doi.org/10.1016/j.contraception.2018.11.003
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Retrospective Cohort Study
1506 deliveries in six
Strengths:
Evaluation of
months with 116
Retrospective study
correlation
Chart review of insertion and receiving PPIUD
allowed comprehensive
between expulsion clinical outcome of 116
(7.7% of births) with
review of pertinent
of PPIUD and
patients receiving PPIUD
75% continued use at 6 information without
PGY level
following a single email
months. 101 placed
having concern of
training of insertion provided manually, 8 placed
fallout from study
Sample/Setting:
to providers.
with ring forceps, 6
116 patients with
with inserter. Only 2
Limitations:
PPIUD at a single
used ultrasound. Using -Varied methods of
facility Cleveland,
the inserter resulted in insertion
OH.
no expulsion and
-Limited population
forceps the highest.
receiving PPIUD
Level of
-One facility results
PGY was not
evidence:
correlated to expulsion - Based on limited
Level II
education re: insertion
in VD.
- Appx 75% follow-up
Conclusion:
Quality of
availability
PPIUD retention is
evidence:
-Single type of IUD
affected by provider
Good
training level and route
of delivery but unclear
which one is the
meaningful factor.

Author Recommendations: More evaluation to determine route of delivery, provider level of
expertise, and method of insertion to examine which is the causative reason for increased expulsion;
larger sample sizes in future studies. More training provided and then reevaluate if PGY level was
correlated to expulsion.
Implications: Skill level of provider may indicate likelihood of expulsion, though later studies
indicated that explicit and comprehensive training may make the larger difference.
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Source: Colwill, A., Schreiber, C., Sammel, M., & Sonalker, S. (2018, March). Six-week retention
after postplacental copper intrauterine device placement. Contraception, 97(3), 215-218.
https://doi.org/10.1016/j.contraception.2017.10.012
Purpose/Sample
Purpose: To
evaluate retention
and complications
of CuIUD use at 6
weeks postpartum
when IUD was
placed immediately
postplacental.
Sample/Setting:
169 women
delivering at
Hospital of the
University of
Pennsylvania
Level of Evidence:
III

Design
(Method/Instruments)
Retrospective Cohort
Study
Retrospective data
collection of copper
IUDs placed within ten
minutes of placenta
removal. 137 vaginal
deliveries were
evaluated and 73
cesarean deliveries were
evaluated. Retention and
complication data was
recorded.

Results

Strengths/Limitations

Conclusion:
Cesarean deliveries had a
higher retention rate than
vaginal deliveries at six
weeks (100% vs. 84%, p
= .01); however cesarean
delivery resulted in
higher rates of more
significant evaluation of
IUD placement like
ultrasonography than post
vaginal delivery
placement because
strings were visible more
often in vaginal delivery
placements (93.1% vs.
44.2%)

Strengths: Strengths of
study include the
comprehensive
documentation of
clinical practice
outcomes.
Limitations:
- 20% of women were
lost to follow-up when
reviewing the postnatal
records due to
retrospective aspect of
the study.
- Limited to copper IUD
only, no LNG-IUS
considered.

Quality: Good

Author Recommendations:
This author recommends studying the clinical significance of PPIUD expulsion further.
Implications: PPIUD should be considered a viable contraceptive method, particularly if postpartum
insurance coverage is lacking or risk of loss of follow-up shows need to capture women at the time of
birth for contraceptive offering.
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Source: Crockett, A. H., Pickell, L., Heberlein, E. C., Billings, D. L., & Mills, B. (2017). Six- and
twelve-month documented removal rates among women electing postpartum inpatient
compared to delayed or interval contraceptive implant insertions after Medicaid payment
reform. Contraception, 95(1), 71–76. https://doi.org/10.1016/j.contraception.2016.07.004
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose: To
Retrospective study of 776
4% total from both
Strengths:
evaluate removal
women using medical record groups reported
Because of the
rates of women
review. Women all received
removal with no
population studied, cost
receiving PPIUD
LNG-IUS from 7/2007statistical difference
and availability did not
vs. interval IUD
6/2014. Comparison of rate
between the two
limit women that
placement.
and reason for removal at 6
groups at 6 months. At otherwise wished to
months and 12 months for
12 months, 12% total
have the device placed.
both PPIUD and interval IUD women reported
Sample/Setting:
placement.
removal. 7% of PPIUD Limitations:
776 Medicaidreported removal at 12 Only studied Medicaid
enrolled women at
months vs. 14% of
population in a state
a regional
outpatient inserts.
that had coverage of
perinatal care
the device. May not be
center in upstate
Conclusion:
relevant for other
SC.
In a setting that
populations.
Medicaid pays for
Level of
LARC, less women
evidence:
removed LNG-IUS
I
devices than their
outpatient
Quality of
counterparts.
evidence:
High

Author Recommendations: Medicaid and insurance payment policies that remove institutional
barriers to PPIUD LARC may optimize family planning desires.

Implications: Most studies focus on inadvertent expulsion; however, this study focused on elective
removal, which was less in PPIUD placements.
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Source: Dahlke, J. D., Terpstra, E. R., Ramseyer, A. M., Busch, J. M., Rieg, T., & Magann, E. F.
(2011). Postpartum insertion of levonorgestrel–intrauterine system at three time periods: A
prospective randomized pilot study. Contraception, 84(3), 244–248.
https://doi.org/10.1016/j.contraception.2011.01.007
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Randomized controlled trial
Use at 6 months was
Strengths:
To determine
comparable in all arms: -3 arms of
efficacy of LNG53 women desired Mirena
93% IPP, 87% EP,
randomization
IUS placement at
birth control and were
94% INT
-Federal facility
three different
randomized into three arms—
without insurance and
intervals.
10 minutes postplacental,
infrastructure
Though there was a
between 10 minutes and 48
constraints
higher rate of
Sample/Setting:
hours post-delivery, and at 6
expulsion in the
46 women in the
week postpartum visit.
Limitations:
PPIUD arm (27%),
Naval Medical
The method of insertion was
-Small sample
many of these
Center at
standardized and post
participants returned to -Sample limited to
Portsmouth
insertion questions regarding care for replacement,
military insured
between Aug 2009 satisfaction were at 3 and 6
patients without
making IUD usage
and Jan 2010.
months postpartum.
insurance limitations
comparable across the
-15 PPIUD
three arms at 3 and 6
insertion
months. The PPIUD
-15 for >10
arm rated pain
minute but <48
significantly less than
hour
the other two groups
-16 delayed
using a visual analog
insertion 6 weeks
scale (1-5 with 5 being
most painful). IPP and
Level of
EP had a scale of 1.07
evidence:
and 1.93 respectively
Level II
while INT had a VAS
of 3.13 with a p =
Quality of
<.001.
evidence:
Good
Author Recommendations:
Future research should include larger sample size and various ways to ensure patient follow-up.
Implications: Immediate postplacental LNG-IUS insertion showed a 27% expulsion rate compared to
5-6% in the 6 week postpartum group. Even with this considered, continued use at both three and six
months was virtually the same in all three arms given that those that had expelled IUDs did have them
reinserted. Additionally, pain during and after insertion was significantly less when placed immediately
postplacentally.
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Source: Glazer, A. B., Wolf, A., & Gorby, N. (2011). Postpartum contraception: Needs vs. reality.
Contraception, 83(3), 238–241. https://doi.org/10.1016/j.contraception.2010.07.002
Purpose/Sample
Purpose:
To determine
whether patient
education about
contraception had
an effect on use of
contraception and
attitude towards
postplacental IUD
offering.

Design
(Method/Instruments)
Retrospective Cohort Study

Results

Strengths/Limitations

77% women recall
Strengths:
discussing birth control Diverse sample of
Written surveys were issued
prenatally and 87%
participants Good
to women postpartum prior to postpartum. 30%
capture of quantitative
discharge from delivery stay
report conversation
data.
to evaluate recollection of
about IUD prenatally
discussing contraception both and 31% in hospital.
Limitations:
prenatally and in the office.
-Low retention rate
23% report that they
Written surveys were also
would have liked the
mailed at 4 and 6 months
option to have an IUD
postpartum to evaluate use of placed postplacentally.
Sample/Setting:
contraception and appeal of a 5% of participants
175 postpartum
postplacental IUD offering.
were using IUD at 6
women in an
months PP with 22%
urban setting in
still awaiting
US
placement. Of those
22%, 62% would have
Level of
elected to have
evidence:
postplacental
Level III
placement if offered.
29% report not using
Quality of
birth control at 6
evidence:
months and 32% report
High
using suboptimal birth
control.
Conclusion:
Contraception
education does not
have a great impact on
contraceptive use.
Offering postplacental
IUD may improve
contraceptive use.
Author Recommendations: While this study corroborates previous limited studies about the lack of
effect counseling has on contraceptive use, more studies are needed to determine the optimal way to
encourage use of contraception.
Implications: Prenatal counseling did not have a large effect on use of contraception. Many women
that desire IUD postpartum are left to wait for placement. Of those waiting, a majority would have
preferred a postplacental option.
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Source: Holland, E., Michelis, L., Sonalkar, S., & Curry, C. L. (2015). Barriers to immediate postplacental intrauterine devices among attending level educators. Women's Health Issues, 25(4),
355–358. https://doi.org/10.1016/j.whi.2015.03.013
Purpose/Sample
Purpose: To
evaluate barriers
to placing PPIUD
for providers

Design
(Method/Instruments)
Qualitative Survey

Results

Strengths/Limitations

42% reported placing a Strengths:
PPIUD. Most common -Breadth of providers
Online survey sent to OB
reason for not placing
(OBGYN, FP, CNM), providers at seven different
included: lack of
-Participant anonymity
facilities, assessing
training (73%),
allows for more honest
knowledge, training, and
uncomfortable (60%),
response
Sample/Setting:
experience.
not available at facility
82 CNM and
(50%). 43%
Limitations:
physicians
appropriately identified Each institution likely
expulsion risk. 25%
did not survey every
Level of
inappropriately
provider
evidence:
believed increased
-No direct
III
perforation risk was
communication with
present. 8% believed
participants,
Quality of
increased infection
Because the survey was
evidence:
risk. 1.2% never an
likely forwarded, there
High
option to place PPIUD, is no way to know
14.5% always an
response rate.
option
- No specifics of when
a provider would
Conclusion:
utilize PPIUD.
Most providers
-Stratification by
reported PPIUD
facility was uneven r/t
acceptable at least
voluntary response.
some of the time
(85%) although there
were knowledge gaps
on risks and providers
IDed need for training
and availability within
facility.
Author Recommendations: Comprehensive surveying of all providers vs. facility targeted choices.
This survey was disseminated in a non-controlled manner and all providers should have opportunity to
respond. This survey is enough evidence to push for amendment of Medicaid policy to positively affect
reimbursement—one of the bigger barriers to implementation. Training and facility policy changes are
also required.
Implications: Although the risk of expulsion is high, the overall benefit of PPIUD to decrease
unintended short interpregnancy interval is greater. Acceptance of practice high but knowledge and
practical application of skill/service is low.
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Source: Jatlaoui, T. C., Marcus, M., Jamieson, D. J., Goedken, P., & Cwiak, C. (2014). Postplacental
intrauterine device insertion at a teaching hospital. Contraception, 89(6), 528–533.
https://doi.org/10.1016/j.contraception.2013.10.008
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Prospective cohort study
88% of participants
Strengths:
To evaluate the
able to be contacted for -Ability to demonstrate
effectiveness and
Women able to choose this
a 19% expulsion rate.
a standardized and
safety of PPIUD
contraception option prior to
Zero pregnancies or
efficient provider
in a teaching
delivery. A one-time training perforations. 11%
training model
facility,
was provided to obstetric
infection rate. No
-Adequate follow-up.
particularly in
residents with refreshers
expulsion difference in
non-expert
every six weeks. Ultrasound
PGY years; biggest
Limitations:
clinicians
and ring forceps were used
difference was parity
-Smaller
each time. 4 week, 6 week
with multiparous
-Limited population
Sample/Setting:
visits established placement
women accounting for demographics.
100 participants
and satisfaction. 3 month and the vast majority of
desiring PPIUD at 6 month surveys evaluated
expulsion; only one
Emory Hospital,
satisfaction and continued
prime expulsion.
Atlanta, GA
use.
Conclusion:
Level of
PPIUD is both safe and
evidence:
effective; additionally,
II
level of training had no
implication to efficacy.
Quality of
evidence:
High infection rate is
High
similar to non-PPIUD
insertion infection rate,
which is high in Fulton
Co, GA.
Author Recommendations: PPIUD can be safely initiated even with no prior experience with PPIUD
insertion and may positively impact unintended pregnancy rate, especially for those otherwise at risk
for non-return to postpartum care. The lack of increased expulsion by lower experienced clinicians is in
contrast to previous literature.
Further studies in expulsion related to parity or anesthesia needed.
Implications: This study showed safe and effective use of PPIUD resulted in zero pregnancies at 6
months regardless of increased expulsion rate. Initiating basic standardized training for PPIUD and
making this an available practice will increase contraceptive use and decrease unintended pregnancy.
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Source: Kumar, S., Srivastava, A., Sharma, S., Yadav, V., Mittal, A., Kim, Y., Nash-Mercado, A.,
Reijneveld, S. A., & Sood, B. (2019). One-year continuation of postpartum intrauterine
contraceptive device: Findings from a retrospective cohort study in India. Contraception,
99(4), 212–216. https://doi.org/p
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Retrospective Cohort
673 of the women had Strengths:
To evaluate use of
PPIUD placement,
Large sample size with
immediate
Telephone survey at one year 62% reported
good follow-up
postpartum
postpartum to determine IUD continued use, 7.5%
CuIUD use at one use, symptoms, and
reported expulsion,
Limitations:
year
alternative contraception
19.3% removal for
-Only one type of IUD
menorrhagia. 50% did used (CuIUD)
Sample/Setting:
not switch to a
-Population
673 randomly
different method.
homogeneous.
selected women in
India
Conclusion:
Use at one year was
Level of
62%. Reason for nonevidence:
use at one year was
III
more related to side
effects like bleeding
Quality of
than expulsion.
evidence:
High

Author Recommendations: Future studies need to focus on the lack of having an alternative method
of contraception.
Implications: Expulsion was low. Because removal was often for CuIUD known side effects, results
may be different with an LNG-IUS
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Source: Laporte, M., Marangoni, M., Surita, F., Juliato, C. T., Miadaira, M., & Bahamondes, L.
(2020). Postplacental placement of intrauterine devices: A randomized clinical trial.
Contraception, 101(3), 153–158. https://doi.org/10.1016/j.contraception.2019.12.006
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Randomized controlled trial
22/60 (36.7%) expelled Strengths:
To compare the
copper IUD. 12/60
-Sample randomization
use of CuIUD
140 women were enrolled to
(20%) expelled LNG-Ultrasonography
versus LNG-IUS
receive a postplacental IUD
IUS (p = 0.12). Higher allowed for more
at 90 days when
placement (half LNG-IUS,
expulsion in vaginal
complete assessment
placed
half TCu380A) regardless of delivery and women on -Good sample retention
postplacentally.
method of delivery. Women
their third or greater
Limitations:
were randomized into type of birth. 33/34 (97%)
-Imbalanced parity and
Sample/Setting:
IUD received. Follow-up was expulsions occurred by age
140 women, 70
performed for verification of the 42 day visit.
No continuous
LNG-IUS and 70
placement at 42 and 90 days
surveillance to
Copper IUD
post birth.
ascertain the exact time
Conclusion:
received
of expulsion (just <6
PPIUD expulsion was
postplacental IUD
weeks postpartum).
higher in copper
placement in
-Short follow-up
CuIUD use, vaginal
Brazil
timeframe
delivery, and women
with three or more
Level of
deliveries. Nearly all
evidence:
occurred in the first six
Level I
weeks postpartum.
Quality of
evidence:
High

Author Recommendations: Recommendations include future studies to focus on type of device,
delivery, and technique for more trending. Additionally, in practice because most of the expulsions
were in the first six weeks postpartum, particular care to surveilling for expulsion should be taken
during this time to prevent unwanted pregnancy or other complications.
Implications: LNG-IUS systems may be a more effective device for PPIUD insertion than Cu devices.
Additionally, most expulsion occurred in the first 6 weeks postpartum.
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Source: Moniz, M. H., Dalton, V. K., Davis, M. M., Forman, J., Iott, B., Landgraf, J., & Chang, T.
(2015). Characterization of medicaid policy for immediate postpartum contraception.
Contraception, 92(6), 523–531. https://doi.org/10.1016/j.contraception.2015.09.014
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Qualitative Study
15 states covered
Strengths:
Identify which
PPIUD; 9 considering
Direct communication
states offer PPIUD Telephone interviews with 40 PPIUD coverage; 16
with policy making
reimbursement
representatives of Medicaid
not considering
agencies.
and potential
agencies to determine trends
coverage. States
barriers to PPIUD in reimbursement and policy
providing coverage
Limitations:
barriers
stated improving
-Not all states in the
Sample/Setting:
overall maternal and
United States elected to
Representatives
child health as well as
participate. 20%
from 40 Medicaid
overall cost savings as missing.
agencies
reason. States
-Reimbursement is
declining to cover
only one layer of the
Level of
stated lack of advocacy barriers that exist with
evidence:
from community
PPIUD.
III
providers and
immediate budget
Quality of
constraints to be the
evidence:
rationale for not
Good
covering.
Conclusion:
Many states provide
Medicaid coverage of
immediate PP LARC.
Misinformation about
clinical effects and
cost-effectiveness
promote moving to
PPIUD insertion.
Author Recommendations: Addressing misinformation about PPIUD insertion and recognizing longterm cost savings are ways to eliminate barriers from PPIUD insertion.
Implications: 15 states in the US cover PPIUD insertion at the time of birth. Of those that don’t,
misinformation, initial cost, and lack of provider desire are the common reasons for omitting this
option.
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Source: Moniz, M. H., Roosevelt, L., Crissman, H. P., Kobernik, E. K., Dalton, V. K., Heisler, M. H.,
& Low, L. (2017). Immediate postpartum contraception: A survey needs assessment of a
national sample of midwives. Journal of Midwifery & Women's Health, 62(5), 538–544.
https://doi.org/10.1111/jmwh.12653
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Qualitative Survey Study
10% felt comfortable
Strengths:
To determine
placing a PPIUD; 64% Large scale assessment
CNM and CM
Online survey discussing
wished to have training of barriers, anonymous,
perceptions on
barriers of PPIUD, current
on method; 20%
accessible survey
PPIUD barriers,
practice, knowledge deficit,
reported access to this
knowledge, and
and desires for further
training; 41% reported Limitations:
current practice
training.
barrier is not standard
-Low response rate
practice; 27% stated
-Self-reporting
Sample/Setting:
not available; 27%
-May not be accurately
4609 CM and
stated inadequate skill; able to translate to
CNM invited to
16.4% were concerned larger??
survey with a 794
about reimbursement;
(17%) rate of
8.4% concerned about
response; 99%
perforation or
female; 92%
expulsion.
white; 45%
Conclusion:
practicing in an
90% of midwives
urban setting
reported not feeling
comfortable with
Level of
PPIUD insertion but
evidence:
64% would like to
Level III
learn more; there is a
significant education
Quality of
gap.
evidence:
High

Author Recommendations:
This study identified a need to assess for didactic and skill training as well as a need to evaluate
barriers in depth such as facility inability to stock IUD for placement and social bias against placement.
Implications: Common barriers such as lack of training, lack of availability, reimbursement concerns,
and misunderstanding of complication risks were identified by a large sample of midwives,
highlighting the need for didactic training on the subject.
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Source: Shukla, M., Qureshi, S., & Chandrawati. (2012). Post-placental intrauterine device insertion-a
five year experience at a tertiary care centre in north India. Indian Journal of Medical
Research, 136(3), 432–435.
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Prospective cohort study
1317 women had IUD Strengths:
To determine the
placed postplacentally. -Large sample size. long-term safety
CuIUD was inserted within
280 did not return for
Adequate follow-up at
and efficacy of
ten minutes of placental
follow-up. Expulsion
least the 6 week visit
PPIUD insertion
delivery. Follow-up with
rate at 6 months was
physical exam and survey at
10.68%. 0%
Limitations:
Sample/Setting:
6 weeks and 6 months
perforation. 0% PID
-Loss to follow-up at 6
1317 women in a
postpartum.
months (22%)
north Indian
-No follow-up past six
Conclusion:
tertiary care center
PPIUD insertion is safe months.
-Only CuIUD
and effective;
Level of
particularly in those at evaluated.
evidence:
risk for loss from
III
postpartum care.
Quality of
evidence:
High

Author Recommendations: Future research should include larger scale study, following patients for
one year or greater to determine efficacy.
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Source: Soon, R., McGuire, K., Salcedo, J., & Kaneshiro, B. (2018). Immediate versus delayed
insertion of the levonorgestrel intrauterine device in postpartum adolescents: A randomized
pilot study. Hawaii Journal of Medicine and Public Health, 77(3), 60–65.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845021/
Purpose/Sample
Purpose: To
evaluate the
feasibility of a
larger scale study
evaluating
adolescents using
IUD at 6 months
when placed
postplacental vs.
postpartum

Design
(Method/Instruments)
Randomized Control Trial
11 adolescents were
randomized into immediate
postplacental IUD insertion
within 10 minutes of placenta
(using hand to fundus or ring
forceps) or 6-8 weeks
postpartum IUD placement.
Follow-up was at 6 weeks
postpartum, 10 weeks
postpartum, and 6 months
postpartum. Evaluation
included pain, bleeding,
satisfaction, and rate of IUD
use.

Results

Strengths/Limitations

All 6 postplacental
Strengths:
placements occurred.
-Randomization
At six weeks 2 of the 5 -No infrastructure
postpartum IUDs
concerns
occurred because of
loss to follow-up,
Limitations:
pregnancy, or no
-Pilot study with a
longer desiring IUD.
small sample size and
the population was
At 6 months, 4/6
limited to adolescents.
postplacental IUDs
-Poor recruitment and
remained with one
retention
non-replacement and
Sample/Setting:
one falling out of
11 adolescents; 6
study. 0 of the 5
receiving
postpartum placements
postplacental IUD
had IUD remaining in
and 5 receiving
place, 2 were pregnant,
postpartum IUD
2 were unable to be
reached. (66% v 0%))
Level of
80% of PPIUD
evidence:
preferred this
Level II
placement time
Conclusion:
Quality of
evidence:
Postplacental IUD
Good
placement may be a
superior way to capture
women for desired
contraception than
traditional postpartum
timing
Author Recommendations: A larger scale study should be performed in a facility that can capture an
adequate population size.
Implications: Postplacental IUD placement may be a more effective way to capture women for
placement of LARC and shorten IPI compared to traditional postpartum placement timelines. Women
are more likely to participate in postpartum follow-up with a device in place at the time of birth and are
less likely to be pregnant or without contraception at six months postpartum than those that receive
IUD at the time of the traditional postpartum visit.
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Source: Sucak, A., Ozcan, S., Çelen, Ş., Çağlar, T., Göksu, G., & Danışman, N. (2015). Immediate
postplacental insertion of a copper intrauterine device: A pilot study to evaluate expulsion rate
by mode of delivery. BMC Pregnancy and Childbirth, 15(1). https://doi.org/10.1186/s12884015-0637-6
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Prospective Cohort Study
At 6 and 12 months,
Strengths: This is the
To look at
vaginal delivery
first time controlled
expulsion risk
160 total women had
experienced an 11.3%
trial has exhibited labor
with PPIUD
CuPPIUD placed. within 10
expulsion rate (no
not having a negative
insertion
minutes postpartum. Follow
expulsion after 6
correlation with
up was performed at 6 weeks, months), unlaboring
expulsion.
Sample/Setting:
6 months, and 12 months to
cesarean 6.5% at six
160 pregnant
determine continued use and
months and 8.7% at 12 Limitations:
women in Ankara, satisfaction of use.
months. Laboring
-Smaller sample size
Turkey.
cesarean 8.9% at 6 and
12 months (p => 0.05
Level of
in all comparisons).
evidence:
Multiparity had a
I
twofold increase in
expulsion.
Quality of
evidence:
Conclusion:
High
Rates of expulsion
were similar and the
only independent
factor in expulsion was
parity.
Author Recommendations: Larger studies needed to determine the effect of parity and labor on
expulsion with PPIUD.
Implications: Parity and provider technique may have less to do with expulsion than laboring PPIUD
placement.
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Source: Whitaker, A. K., Endres, L. K., Mistretta, S. Q., & Gilliam, M. L. (2014). Postplacental
insertion of the levonorgestrel intrauterine device after cesarean delivery vs. delayed insertion:
A randomized controlled trial. Contraception, 89(6), 534–539.
https://doi.org/10.1016/j.contraception.2013.12.007
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Randomized controlled trial
Rate of use was 60% at Strengths:
To compare rate
twelve months in the
Underestimation of
of use of LNGThe two randomized arms
postplacental group
return to care at 6
IUS when placed
were immediate (n = 20) vs.
and 40% in the interval weeks may have much
postplacentally
delayed (n = 22) postpartum
placement group.
to do with the
compared to the
IUD insertion. Follow-up
population being one
Rate of expulsion was
traditional interval assessments with telephone
that would most benefit
20% in the PPIUD
placement of 4-8
surveys performed at 3, 6,
from placement
group vs 0% in the
weeks post birth
and 12 months including
interval group (p = .01)
satisfaction and rate of
Limitations:
Sample/Setting:
expulsion and continued use. Conclusion:
-Poor sample retention
42 women.
rate at 33.3% in both
Higher expulsion
Two urban
groups.
postplacentally but
medical centers in
-Study was halted early
similar use at 12
Chicago.
due to slow enrollment.
months, Insufficient
sample size to power
Level of
for statistical
evidence:
difference
I
Quality of
evidence:
Low

Author Recommendations: Future studies needed with better ability to reach a definitive conclusion
through enhanced retention.
Implications: While this study was unable to power for statistical differences, the higher than expected
return for care for IUD placement may suggest the desire of these at-risk populations to have access to
contraception with the two visit IUD practice limiting access to obtaining family planning.

